Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 1
2012 5
2013 6
2014 1
2015 3
2016 1
2018 1
2020 1
2022 1
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
Zhu AX, Finn RS, Edeline J, Cattan S, Ogasawara S, Palmer D, Verslype C, Zagonel V, Fartoux L, Vogel A, Sarker D, Verset G, Chan SL, Knox J, Daniele B, Webber AL, Ebbinghaus SW, Ma J, Siegel AB, Cheng AL, Kudo M; KEYNOTE-224 investigators. Zhu AX, et al. Lancet Oncol. 2018 Jul;19(7):940-952. doi: 10.1016/S1470-2045(18)30351-6. Epub 2018 Jun 3. Lancet Oncol. 2018. PMID: 29875066 Clinical Trial.
A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer.
Knox JJ, McNamara MG, Bazin IS, Oh DY, Zubkov O, Breder V, Bai LY, Christie A, Goyal L, Cosgrove DP, Springfeld C, Sjoquist KM, Park JO, Verdaguer H, Braconi C, Ross PJ, De Gramont A, Shroff RT, Zalcberg JR, Palmer DH, Smith JR, Oelmann E, Bruce T, Valle JW. Knox JJ, et al. Among authors: cosgrove dp. J Hepatol. 2025 Aug;83(2):358-366. doi: 10.1016/j.jhep.2025.01.040. Epub 2025 Feb 18. J Hepatol. 2025. PMID: 39978598 Clinical Trial.
Image of the month-quiz case.
Kneuertz PJ, Malla M, Cosgrove DP, Herman JM, Kamel IR, Geschwind JF, Cameron AM, Pawlik TM. Kneuertz PJ, et al. Among authors: cosgrove dp. Arch Surg. 2012 Oct 1;147(10):973. doi: 10.1001/archsurg.2011.1505a. Arch Surg. 2012. PMID: 24901513 No abstract available.
Diabetes and pancreatic cancer.
Chaudhry ZW, Hall E, Kalyani RR, Cosgrove DP, Yeh HC. Chaudhry ZW, et al. Among authors: cosgrove dp. Curr Probl Cancer. 2013 Sep-Oct;37(5):287-92. doi: 10.1016/j.currproblcancer.2013.10.006. Epub 2013 Oct 8. Curr Probl Cancer. 2013. PMID: 24331184 Review. No abstract available.
The PIK3CA gene as a mutated target for cancer therapy.
Gustin JP, Cosgrove DP, Park BH. Gustin JP, et al. Among authors: cosgrove dp. Curr Cancer Drug Targets. 2008 Dec;8(8):733-40. doi: 10.2174/156800908786733504. Curr Cancer Drug Targets. 2008. PMID: 19075596 Free PMC article. Review.
Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization.
Fan KY, Wild AT, Halappa VG, Kumar R, Ellsworth S, Ziegler M, Garg T, Rosati LM, Su Z, Hacker-Prietz A, Pawlik TM, Cosgrove DP, Hong KK, Kamel IR, Geschwind JF, Herman JM. Fan KY, et al. Among authors: cosgrove dp. Contemp Clin Trials. 2016 Sep;50:143-9. doi: 10.1016/j.cct.2016.08.001. Epub 2016 Aug 9. Contemp Clin Trials. 2016. PMID: 27520932
23 results